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1. Introduction
Strokes are the fourth ranked cause of death, and each 
year, leave millions of people severely disabled. The 
most common are ischaemic strokes which occur 
when a region of the brain is deprived of oxygenated 
blood supply, usually due to direct occlusion of 
arterial vessels. There is Class I, Level A evidence that 
ischaemic strokes can be prevented by anti-platelet 
agents (1).
 The convent ional  l i s t  of  ischaemic s t roke 
risk factors is headed by smoking, hypertension, 
hypercholesterolaemia, obesity and diabetes, with a 
focus on atherosclerotic-based mechanisms. However, 
these risk factors do not explain the very high burden of 
ischaemic stroke in low income countries (2). 
 The rare disease state of pulmonary arteriovenous 
malformations (PAVMs) provides an alternative 
perspective. PAVMs are abnormal dilated vascular 
channels that provide a direct communication between 
pulmonary arteries and pulmonary veins, and hence 
a right-to-left shunt (Figure 1). In cross-sectional 
studies, approximately one in eight patients with 
PAVMs experience a clinical stroke (3,4) with imaging 
revealing a far higher ischaemic burden: in a study 
performed using 20th century scanners, 34/67 (51%) 
patients with median age 41 year had evidence of 
cortical or subcortical infarcts (5).
 The general presumption was that the infarcts/
strokes in PAVM patients developed as a result of 
paradoxical emboli of venous thromboemboli (VTE), 
and that stroke risk would increase with the severity 
of PAVMs. Surprisingly however, a prospective series 
of 219 patients published in 2008 demonstrated no 
clear link between ischaemic stroke and severity of 
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PAVMs, venous thromboemboli, or conventional 
stroke risk factors (3).  Further exploration of factors 
that contributed to the risks of these strokes was 
recommended (3).
2. Iron deficiency and ischaemic strokes
Understanding which PAVM patients are at higher risk 
of ischaemic stroke is important for patients, because 
while treatment by embolisation reduces stroke risk (3), 
individual PAVMs are often too small for embolisation, 
and most treated patients are left with residual right-to-
left shunts. Additionally, it seemed plausible that the 
stroke risks for patients with right-to-left shunts due to 
PAVMs may also be relevant to individuals with other 
right-to-left shunts such as patent foramen ovale (3) 
which persist in approximately 30% of adults in the 
general population (6) (Figure 1). 
2.1. Iron deficiency and ischaemic strokes due to 
PAVMs
Earlier this year, a study in 497 consecutive adults 
with PAVMs identified low serum iron levels, and high 
levels of fibrinogen (the predominant plasma protein 
for platelet adhesion), as new risk factors for ischaemic 
strokes in the population (4).The age/gender adjusted 
odds ratio of 0.96 (95% CI: 0.92, 1.00), per μmol/L 
increase in serum iron, implied that a modest reduction 
in serum iron would be associated with approximately 
double the risk of stroke. In the PAVM patients, iron 
deficiency was attributed to inadequate replacement of 
haemorrhagic iron losses due to underlying hereditary 
haemorrhagic telangiectasia (HHT), particularly 
nosebleeds (7).
 As in the previous study, there were no associations 
between ischaemic stroke and known vascular risk 
factors: almost half of all strokes (29/61, 47.5%) occurred 
in lifelong non-smokers without any documented 
conventional stroke risk factors (hypertension, 
hypercholesterolemia, diabetes, or arrhythmias) (3,4). 
There was also no association between stroke risk 
and markers or outcomes of conventional venous 
thromboemboli (often considered responsible for 
paradoxical embolic events), or with platelet number 
or haemoglobin that are commonly cited as possible 
mediators of iron deficiency risks (4). There was an 
overlap with myocardial infarction, attributed to a 
common paradoxical process (4).
2.2. Iron deficiency and ischaemic stroke in the general 
population
This was not the first report to link iron deficiency 
to ischaemic stroke. Case reports and small series 
have generally focused on paediatric populations (8, 
and references), but major epidemiological studies 
in adults also support a link between iron deficiency 
and ischaemic stroke, operating independently to 
known stroke risk factors (9,10, and references). Iron 
deficiency would offer a plausible missing risk factor 
for stroke pathogenesis, because it affects in excess 
of 1 billion individuals worldwide, and is a particular 
problem in countries with restricted diets, and where 
iron losses are increased, for example due to hookworm 
and/or urinary schistosomiasis (7,11).
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Figure 1. The pulmonary capillary filter and right-to-left shunts. Cartoon of the circulations, indicating the pulmonary capillary 
bed and the mechanical filter through which venous blood should pass before returning to the systemic arterial tree. Red arrows 
represent right-to-left shunts which allow venous blood to return to systemic arteries having bypassed filtration, gas exchange, and 
other pulmonary capillary functions. Right-to-left shunting is continuous through pulmonary AVMs, but only intermittent through 
intracardiac shunts such as patent foramen ovale, when flow is predominantly left-to-right (blue arrow, see text). Note that the lungs 
have a second arterial supply from the systemic circulation (bronchial vessels indicated) that can preserve arterial supply to lung 
tissue if the pulmonary circulation is compromised.
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lodge safely in pulmonary capillaries/arterioles. In man, 
morphometric, perfusion, and echocardiographic studies 
indicate that the cut off size for pulmonary capillary 
transit just exceeds the 7μm diameter of erythrocytes 
(4). The filter is exploited by conventional nuclear 
perfusion scans performed to diagnose pulmonary 
emboli: technetium-labelled albumin macroaggregates 
are injected intravenously, and impact in pulmonary 
capillaries receiving pulmonary arterial flow.
4.2. PAVMs allow blood-bourne particles to bypass 
pulmonary capillary filtration
If the pulmonary capillary filter were breached, for 
example if venous blood could pass through the right-
to-left shunts of PAVMs, it would be expected that a 
proportion of venous particulate matter would impact 
not in the lungs, but in next (systemic) capillary bed. 
This is observed if perfusion scans are performed in 
patients with PAVMs, with striking cerebral images 
(4). The final clinical outcome following neurovascular 
impaction is more difficult to predict, and will depend 
on end organ thrombo-inflammatory and other vascular/
tissue responses -clearly very few impactions result in a 
clinical stroke.
5. Patent foramen ovale (PFO) and intracardiac 
shunts
Could intracardiac shunts that affect at least 1 in 3 of 
the general population, provide a rationale for the iron 
deficiency- ischaemic stroke associations in children 
and adults? Recent AHA guidelines detail management 
strategies for ischaemic strokes associated with PAVMs 
in the same section as patent foramen ovale (PFO), 
recommending anti-platelet agents for secondary 
prevention in both conditions (Class IIa, Level B 
Evidence) (1). 
 In contrast to PAVMs, only a small proportion of 
individuals with PFO suffer ischemic strokes, but stroke 
rates are higher in the subgroup of PFO patients with 
permanent right-to-left shunts (18).
 The discrepant stroke rates make intuitive sense 
in the light of physiological comparisons of right-to-
left shunting through pulmonary AVMs, compared to 
intracardiac defects such as PFOs. Pulmonary AVMs 
provide almost continuous right-to-left shunts because 
the pressure in the pulmonary artery generally exceeds 
that of the pulmonary vein: shunt quantifications are 
highly reproducible within the same patient (4,12). 
PFOs and other intracardiac septal defects normally 
exhibit left-to-right flow, due to the higher pressure 
at equivalent points in the systemic compared to 
pulmonary circulation (Figure 1). At the end of valsalva 
manouvres however, pressure changes result in reversal 
of flow across such septal defects, and a transient right-
to-left shunt (18).
3. Iron deficiency and platelets
Iron deficiency has multiple effects that could be 
implicated in stroke pathogenesis, including anaemia/
reduced blood oxygen content, high cardiac output 
with lower systemic vascular resistance, increased 
blood viscosity, and thrombocythaemia (12,13). Many 
were discussed in the respective stroke manuscripts 
(8-10 and references), but do not really stand up to 
careful scrutiny as likely primary mechanisms for focal 
ischaemic strokes (4). Given the proven efficacy of 
anti-platelet agents in stroke prevention (1), it seems 
surprising that a study linking iron deficiency to 
exuberant platelet aggregation(14) has been overlooked 
until now (4).
 Four decades ago, the Oxford-based authors 
demonstrated increased platelet aggregation to serotonin 
(5-hydroxytryptamine, 5HT) (14). As confirmed and 
recently reviewed (4), the platelet response is relatively 
specific, with no difference observed in platelet 
aggregation responses to adenosine diphosphate (ADP). 
In many countries, 5HT is considered a minor platelet 
agonist, but evidence particularly from Japan suggests 
otherwise: Plasma 5HT concentrations increase after 
platelet activation, and in a number of pathologies 
and disease states including atherosclerosis (4,15,16). 
Critically, antagonists to the receptor 5HT2A result in 
dose-dependent inhibition of platelet aggregation in 
ischemic stroke patients (15), and achieved therapeutic 
equivalence with aspirin in secondary prevention of 
ischaemic stroke (16). Conversely, cardiovascular 
side effects are recognised for drugs that increase 
extracellular 5HT/serotonin, such as serotonin reuptake 
inhibitors (SSRIs) (17).
 Taken together,  these data suggest that for 
individuals with concurrent iron deficiency and a state 
associated with elevated plasma 5HT, exuberant platelet 
aggregation might be predicted.
4. PAVMs and compromised pulmonary capillary 
filtration
The 5HT/platelet data could be relevant to platelet 
aggregation during atherothrombotic events at 
arterial walls. However, multiple studies implicate 
iron deficiency in ischaemic stroke pathogenesis in 
children too young to have accumulated a significant 
atherosclerotic load (8 and references). Furthermore, 
as noted above, conventional atherosclerotic-based risk 
factors were not a feature of the PAVM patients with 
ischaemic strokes (3,4). A different paradigm seems to 
be needed.
4.1. The pulmonary capillary filter
After forming or entering the venous circulation, 
particulate matter and multicellular aggregates should 
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 This is important because valsalva manouvres 
occurs surprisingly frequently during daily life, for 
example during nasal/sinus clearance and strained 
bowel evacuations (18). Times when PFO right-to-left 
shunts would be in operation also include sleep apnoea, 
now recognised to be associated with ischaemic stroke 
and other adverse cardiovascular events (19,20). 
Associated pressure changes are well recognised, but 
valsalva provocation of right-to-left shunting, allowing 
the particulate constituents of venous blood to bypass 
the mechanical filter provided by the pulmonary 
capillary bed, has not been emphasised to date.
6. Future studies
Examining whether paradoxical embolism of venous 
platelet-based aggregates is likely to be contributing to 
ischaemic stroke risks in the general population could 
be relatively easy to address, particularly given the lead 
through iron deficiency.
 First, future epidemiological studies of associations 
between iron deficiency and ischaemic stroke could test 
the null hypothesis that the presence of a PFO, or any 
form of right-to-left shunt, does not modify the odds 
ratio for stroke attributable to iron deficiency. It may be 
possible to address this retrospectively using subgroups 
of published series in which contrast echocardiographic 
studies have been undertaken (8-10).  
 Prospective studies could also test whether 
exuberant platelet aggregation to 5HT is associated 
with enhanced risk of ischaemic stroke, and whether 
contribution of iron deficiency to the stroke model 
is reduced once adjusted for the platelet aggregation 
phenotype.
 Most importantly, it would seem wise that for future 
randomised controlled trials examining the potential 
efficacy of prevention/treatment of iron deficiency 
in stroke prevention, additional assessments should 
be incorporated in order to allow appropriate risk 
stratifications of physiological groupings. Suggestions 
include contrast echocardiographic  studies to evaluate 
right-to-left shunts, capturing a history of valsalva-
precipitating clinical events in study populations, and 
concurrent assessments of platelet 5HT aggregation 
responses. For secondary prevention when it would 
be unethical to withhold anti-platelet therapy, further 
comparisons of the relative efficacy of 5HT receptor 
antagonists versus compounds such as aspirin or 
clopidogrel could be made, capturing whether any 
differences were more or less evident in subgroups 
stratified by iron deficiency or echocardiographic 
evidence of shunting.
7. Conclusion
For society and individuals, the ultimate burden 
of ischaemic strokes both directly, and through 
contributions of small ischaemic strokes to vascular 
dementia, is profound. The identification of iron 
deficiency as a risk factor for ischaemic strokes in 
the rare disease of PAVMs appears to introduce new 
paradigms for stroke pathogenesis. Given the current 
evidence base, and prevalence of both compromised 
pulmonary capillary filtration and iron deficiency, it 
seems appropriate to now test the platelet-serotonin-
shunt hypothesis, and establish the extent to which 
the pulmonary capillary filter prevents ischaemic 
strokes and other infarct-mediated pathologies such as 
myocardial infarction.
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